A clinical trial found that metformin, a drug typically used for type 2 diabetes, reduced insulin requirements by around 12% ...

Despite being a cornerstone therapy for individuals with Type 1 and many with Type 2 diabetes, insulin is still administered as subcutaneous injections. However, as we push for better outcomes it’s ...

Scientists at the Research Center for Molecular Medicine of the Austrian Academy of Sciences have demonstrated that targeting the chromatin protein SMNDC1 will stimulate alpha cells to produce insulin ...

Insulin resistance is concomitant with type 2 diabetes, obesity, hypertension, and other features of the metabolic syndrome. Because insulin resistance is associated with cardiovascular disease, both ...

Consequently, those with type 1 diabetes must administer insulin for the rest of their lives to regulate blood sugar levels.

A cheap, century-old medication can improve life for people with type 1 diabetes, according to new research. A clinical trial ...

Insulin glargine (Lantus ®, sanofi-aventis) claims to have a 24-hour duration of action. Is there any advantage to using it twice daily? If so, what patient population might benefit from twice-daily ...

Metformin treatment in type 1 diabetes lowers insulin dosage but does not improve insulin resistance, highlighting its ...